WSFS
IMVT icon

Wilmington Savings Fund Society’s Immunovant IMVT Stock Holding History

Wilmington Savings Fund Society’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-24
Closed -$594 – 2111
2024
Q4 		$594 Hold
24
– – ﹤0.01% 2032
2024
Q3 		$684 Buy
+24
New +$708 ﹤0.01% 2005

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

Wilmington Savings Fund Society's IMVT Position: Q1 2025 in Review

Wilmington Savings Fund Society sold out of Immunovant (IMVT) in Q1 2025, closing a stake of 24 shares — an estimated $594 sold.

Wilmington Savings Fund Society first reported a position in IMVT in Q3 2024 and held it in 2 quarters. The position peaked at $684 in Q3 2024. 193 funds tracked by Wall St. Rank hold IMVT as of Q1 2025.

  • Wilmington Savings Fund Society reported no remaining Immunovant position as of Q1 2025 after selling out during the quarter.
  • Wilmington Savings Fund Society sold 24 Immunovant shares in Q1 2025, an estimated $594.
  • Wilmington Savings Fund Society first reported a position in Immunovant in Q3 2024 and held it in 2 quarters.
  • Wilmington Savings Fund Society's Immunovant position peaked at $684 in Q3 2024.
  • 193 funds tracked by Wall St. Rank held Immunovant as of Q1 2025.

Based on Wilmington Savings Fund Society's 13F filing for Q1 2025, filed 8 May 2025.